Journal Articles
Ma, Sean S. Q., Henry, Claire E., Llamosas, Estelle, Higgins, Rupert, Daniels, Benjamin, Hesson, Luke B., Hawkins, Nicholas J., Ward, Robyn L. and Ford, Caroline E. (2017). Validation of specificity of antibodies for immunohistochemistry: the case of ROR2. Virchows Archiv, 470 (1), 99-108. doi: 10.1007/s00428-016-2019-5
Ma, Sean S. Q., Henry, Claire E., Llamosas, Estelle, Higgins, Rupert, Daniels, Benjamin, Hesson, Luke B., Hawkins, Nicholas J., Ward, Robyn L. and Ford, Caroline E. (2016). Erratum to: Validation of specificity of antibodies for immunohistochemistry: the case of ROR2. Virchows Archiv, 469 (6), 717-717. doi: 10.1007/s00428-016-2036-4
Ma, Sean S. Q., Srivastava, Sameer, Llamosas, Estelle, Hawkins, Nicholas J., Hesson, Luke B., Ward, Robyn L. and Ford, Caroline E. (2016). ROR2 is epigenetically inactivated in the early stages of colorectal neoplasia and is associated with proliferation and migration. BMC Cancer, 16 (1) 508, 508. doi: 10.1186/s12885-016-2576-7
Henry, Claire, Llamosas, Estelle, Knipprath-Meszaros, Alexandra, Schoetzau, Andreas, Obermann, Ellen, Fuenfschilling, Maya, Caduff, Rosemarie, Fink, Daniel, Hacker, Neville, Ward, Robyn, Heinzelmann-Schwarz, Viola and Ford, Caroline (2015). Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion. Oncotarget, 6 (37), 40310-40326. doi: 10.18632/oncotarget.5643
Henry, C., Quadir, A., Hawkins, N.J., Jary, E., Llamosas, E., Kumar, D., Daniels, B., Ward, R.L. and Ford, C.E. (2015). Expression of the novel Wnt receptor ROR2 is increased in breast cancer and may regulate both β-catenin dependent and independent Wnt signalling. Journal of Cancer Research and Clinical Oncology, 141 (2), 243-254. doi: 10.1007/s00432-014-1824-y
Ford, C. E., Punnia-Moorthy, G., Henry, C. E., Llamosas, E., Nixdorf, S., Olivier, J., Caduff, R., Ward, R. L. and Heinzelmann-Schwarz, V. (2014). The non-canonical Wnt ligand, Wnt5a, is upregulated and associated with epithelial to mesenchymal transition in epithelial ovarian cancer. Gynecologic Oncology, 134 (2), 338-345. doi: 10.1016/j.ygyno.2014.06.004
Conference Papers
Henry, C. E., Knipprath-Meszaros, A. M., Llamosas, E., Schotzau, A., Obermann, E., Fink, D., Hacker, N., Ward, R. L., Heinzelmann-Schwarz, V. and Ford, C. E. (2015). Ror2 is a novel target of the Wnt signaling pathway involved in metastasis and chemotherapy resistance. 19th International Meeting of the European Society of Gynaecological Oncology (ESGO 2015), Nice, France, 24 - 27 October 2015. London, United Kingdom: Lippincott Williams & Wilkins.
Ford, C. E., Henry, C. E., Llamosas, E., Djordjevic, A., Hacker, N. F., Heinzelmann-Schwarz, V. A. and Ward, R. L. (2014). Hear the Ror! the Role of WNTÂ Signalling in Ovarian Cancer. 15th Biennial Meeting of the International Gynecologic Cancer Society, Melbourne, Australia, 8-11 November 2014. Philadelphia, USA: Lippincott, Williams & Wilkins.